Patent ID: 8889663
Filing Date: 2014-11-18
Classification: A61K,A61P

Abstract:
1. A formulation for oral transmucosal administration of at least one lipid-lowering drug and/or cardiovascular protection active principle, the formulation comprising: said lipid-lowering drug and/or cardiovascular protection active principle, the dose of said active principle being less than 8 mg, wherein the active principle is selected from the group consisting of statins, fibrates and ezetimibe; an aqueous alcohol solution based on water and ethanol titrating between 45° and 65° ethanol, in which said active principle is present in a stable and completely dissolved state, the volume of said aqueous alcohol solution being less than 2 mL, and said aqueous alcohol solution being the only solvent in said formulation; and wherein the pH of the formulation is between 5.5 to 7.5.